Atracurium Besylate
NDC 71288-701, Atracurium Besylate, injection, solution, from Meitheal Pharmaceuticals Inc..
- Product NDC
- 71288-701
- Status
- Listed
- Labeler
- Meitheal Pharmaceuticals Inc.
- Dosage form
- INJECTION, SOLUTION
- Route
- INTRAVENOUS
- Product type
- HUMAN PRESCRIPTION DRUG
- Marketing category
- ANDA
- Application
- ANDA091488
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/71288-701 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- ATRACURIUM BESYLATE10 mg/mL
Pharmacologic classes
Neuromuscular Nondepolarizing Blockade [PE]; Nondepolarizing Neuromuscular Blocker [EPC]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 71288-701-05 | 71288070105 | 10 VIAL, SINGLE-DOSE in 1 CARTON (71288-701-05) / 5 mL in 1 VIAL, SINGLE-DOSE (71288-701-06) |
Linked data
RxNorm, label and prices
RxNorm concepts
Related lookups
FDA label sections
GET /v1/drugs/labels/efe90ee2-fe9e-421f-9e54-2961085d3b12
Use it
Look up 71288-701 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/71288-701 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 71288-701. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.